Effect of endotoxin on hormonal responses to thyrotropin and thyrotropin-releasing hormone in dogs

American Journal of Veterinary Research

Volumn 59, Issue 2, 1998, Pages 186-191

  Yu, Anthony A ^a,b   Kemppainen, Robert J ^a   MacDonald, John M ^a  

^a AUBURN UNIVERSITY   (United States)

^b Anim Allerg Skin Clin of Oregon   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3',5' TRIIODOTHYRONINE; CORTICOTROPIN; ENDOTOXIN; HYDROCORTISONE; LIOTHYRONINE; PROTIRELIN; THYROTROPIN; THYROXINE;

ANIMAL; ARTICLE; BLOOD; DOG; DRUG EFFECT; FEMALE; MALE; PHYSIOLOGY; REGRESSION ANALYSIS; SECRETION; THYROID GLAND; TIME;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; DOGS; ENDOTOXINS; FEMALE; HYDROCORTISONE; MALE; REGRESSION ANALYSIS; THYROID GLAND; THYROTROPIN; THYROTROPIN-RELEASING HORMONE; THYROXINE; TIME FACTORS; TRIIODOTHYRONINE; TRIIODOTHYRONINE, REVERSE;

EID: 0031989428     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Nelson RW, Ihle SL, Feldman EC, et al. Serum free thyroxine concentrations in healthy dogs, dogs with hypothyroidism, and euthyroid dogs with concurrent illness. J Am Vet Med Assoc 1991;198:1401-1407.
2. Feldman EC, Nelson RW. Canine and feline endocrinology and reproduction. Philadelphia: WB Saunders Co, 1987;55-90.
3. Ferguson DC. Update on the diagnosis of canine hypothyroidism. Vet Clin North Am Small Anim Pract 1994;24:515-539.
4. Beale KM. Current diagnostic techniques for evaluating thyroid function in the dog. Vet Clin North Am Small Anim Pract 1990; 20:1429-1441.
5. Wheeler SL, Husted PW, Rosychuk RAW, et al. Serum concentrations of thyroxine and 3,5,3′-triiodothyronine before and after intravenous or intramuscular thyrotropin administration in dogs. Am J Vet Res 1985;46:2605-2608.
6. Nelson RW, Feldman EC. Indications and interpretation of endocrine tests used in the dog and cat. Semin Vet Med Surg Small Anim 1992;7:285-291.
7. Peterson ME. The use of endocrine testing in the diagnosis and treatment of endocrine disorders, in Proceedings. 9th ACVIM Forum, 1991;109-117.
8. Paradis M, Lepine S, Lemay S, et al. Studies of various diagnostic methods for canine hypothyroidism. Vet Dermatol 1991;2: 125-132.
9. Peterson ME, Ferguson DC. Thyroid diseases. In: Ettinger SJ, ed. Textbook of veterinary internal medicine. Vol 2. 3rd ed. Philadelphia: WB Saunders Co, 1989;1632-1675.
10. Miller AB, Nelson RW, Scott-Montcrieff JC, et al. Serial thyroid hormone concentrations in healthy euthyroid dogs, dogs with hypothyroidism, and euthyroid dogs with atopic dermatitis. Br Vet J 1992;148:451-458.
11. Griffin JE. The thyroid. In: Griffin JE, Ojeda SR, ed. Textbook of endocrine physiology. 2nd ed. Oxford: Oxford University Press, 1992;224-246.
12. Utiger RD. Decreased extrathyroidal triiodothyronine production in nonthyroidal illness: benefit or harm? Am J Med 1980;69: 807-810.
13. Slag MF, Morley JE, Elson MK, et al. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 1981; 245:43-45.
14. Kaptein EM, Weiner JM, Robinson WJ, et al. Relationship of altered thyroid hormone indices to survival in nonthyroidal illnesses. Clin Endocrinol 1982;16:565-574.
15. Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 1986;63:1-8.
16. Lothrop CD Jr, Tamas PM, Fadok VA. Canine and feline thyroid function hormone assessment with the thyrotropin-releasing hormone response test. Am J Vet Res 1984;45:2310-2313.
17. Evinger JV, Nelson RW, Bottoms GD. Thyrotropin releasing hormone stimulation testing in healthy dogs. Am J Vet Res 1985; 46:1323-1325.
18. Kaufman J, Olson PN, Reimers TJ, et al. Serum concentrations of thyroxine, 3,5,3′ triiodothyronine, thyrotropin, and prolactin in dogs before and after thyrotropin-releasing hormone administration. Am J Vet Res 1985;46:486-492.
19. Chopra IJ, Chopra U, Smith SR, et al. Reciprocal changes in serum concentrations of 3,3′,5′-triiodothyronine (rT3) and 3,3′,5-triidodothyronine (T3) in systemic illness. J Clin Endocrinol Metab 1975;41:1043-1049.
20. Felicetta JV. Effects of illness on thyroid function tests. Postgrad Med 1989;85:213-215.
21. Kasting NW, Martin JB. Altered release of growth hormone and thyrotropin induced by endotoxin in the rat. Am Physiol Soc 1982;E332-E337.
22. Hermus ARMM, Sweep CGJ, Van der Meer MJM, et al. Continuous infusion of interleukin-1 beta induces a nonthyroidal illness syndrome in the rat. Endocrinology 1992;131:2139-2146.
23. Wessels BC, Wells MT. Antiendotoxin immunotherapy for canine pyometra endotoxemia. J Am Anim Hosp Assoc 1989;25: 455-460.
24. Morrison DC, Ryan JL. Endotoxins and disease mechanisms. Ann Rev Med 1987;38:417-432.
25. Kasing NW, Cooper KE, Veale WL. Vasopressin: a homeostatic effector in the febrile processes. Neurosci Biobehav Rev 1982;6:215-222.
26. Kemppainen RJ, Sartin JL. Evidence for episodic but not circadian activity in plasma concentrations of adrenocorticotropin, cortisol, and thyroxine in dogs. J Endocrinol 1984;103:219-226.
27. Young DW, Sartin JL, Kemppainen RJ. Abnormal canine triiodothyronine-binding factor characterized as a possible triiodothyronine autoantibody. Am J Vet Res 1985;46:1346-1350.
28. Kemppainen RJ, Thompson FN, Lorenz MD. Use of a low dose synthetic ACTH challenge test in normal and prednisone treated dogs. Res Vet Sci 1983;35:240-242.
29. Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall Inc, 1984.
30. Thomopoulos P. Thyroid dysfunctions. In: Pinsky MR, Dhainaut J-F, eds. Pathophysiologic foundations of critical care. Baltimore: The Williams & Wilkins Co, 1993;891-917.
31. Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the euthyroid-sick syndrome. Endocrinol Rev 1982;3:164-217.
32. Maliszewski CR. CD14 and immune response to lipopolysaccharide. Science 1991;252:1321-1322.
33. Rettori V, Milenkovic L, Beutler BA, et al. Hypothalamic action of cachectin to alter pituitary hormone release. Brain Res Bull 1989;23:471-475.
34. Van Der Poll T, Romijn JA, Wiersinga WM, et al. Tumor necrosis factor: a putative mediator of sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990;71:1567-1572.
35. Pang XP, Hershman JM, Mirell CJ, et al. Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-alpha (cachectin). Endocrinology 1989;125:76-84.
36. Ozama M, Sato K, Han DC, et al. Effect of tumor necrosis factor-alpha/cachectin on thyroid hormone metabolism in mice. Endocrinology 1988;123:1461-1467.
37. Chopra IJ, Sakane S, Teco GN. A study of the serum concentration of tumor necrosis factor-alpha in thyroidal and nonthyroidal illnesses. J Clin Endocrinol Metab 1991;72:1113-1116.
38. Koenig JI, Snow K, Clark BD, et al. Intrinsic interleukin-1 beta is induced by bacterial lipopolysaccharide. Endocrinology 1990;126:3053-3058.
39. Spangelo BL, MacLeod RM, Isakson PC. Production of interleukin-6 by anterior pituitary cells in vitro. Endocrinology 1990; 126:582-586.
40. Rasmussen AK, Kayser L, Bech K, et al. Influence of interleukin 6 on the function of secondary cultures of human thyrocytes. Acta Endocrinol 1991;124:577-582.
41. Grubeck-Loebenstein B, Buchan G, Chantry D, et al. Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1 alpha and interleukin-6. Clin Exp Immunol 1989;77:324-330.
42. Bendtzen K, Buschard K, Diamant M, et al. Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Lymphokine Cytokine Res 1989;8: 335-340.
43. Franklyn JA, Sheppard MC, Ramsden DB, et al. Measurement of free thyroxine and free triiodothyronine in thyrotoxicosis and hypothyroidism. Clin Endocrinol 1984;20:107-110.
44. Chopra IJ, Van Herle AJ, Teco GN, et al. Serum free thyroxine in thyroidal and nonthyroidal illnesses: a comparison of measurements by radioimmunoassay, equilibrium dialysis, and free thyroxine index. J Clin Endocrinol Metab 1980;51:135-143.
45. Chopra IJ, Teco GN, Mead JF, et al. Relationship between serum free fatty acids and thyroid hormone binding inhibitor in nonthyroidal illnesses. J Clin Endocrinol Metab 1985;60:980-984.
46. Chopra IJ, Teco GN, Nguyen AH, et al. In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroidal illnesses. J Clin Endocrinol Metab 1979;49:63-69.
47. Kaptein EM. Thyroid hormone metabolism in illness. In: Hennemann G, ed. Thyroid hormone metabolism. New York: Marcel Dekker, 1986;297-333.
48. Okamura K, Ueda K, Sone H, et al. A sensitive thyroid stimulating hormone assay for screening of thyroid functional disorder in elderly Japanese. J Am Geriatr Soc 1989;37:317-322.
49. Faber J, Kirkegaard C, Rasmussen B, et al. Pituitary-thyroid axis in critical illness. J Clin Endocrinol Metab 1987;65:315-320.
50. Heinen E, Herrmann J, Konigshausen T, et al. Secondary hypothyroidism in severe nonthyroidal illness? Horm Metab Res 1981;13:284-288.
51. Ferguson DC, Peterson ME. Serum free and total iodothyronine concentrations in dogs with hyperadrenocorticism. Am J Vet Res 1992;53:1636-1640.
52. Fujii T, Sato K, Ozawa M, et al. Effect of interleukin-1 (IL-1) on thyroid hormone metabolism in mice: stimulation by IL-1 of iodothyronine 5'-deiodinating activity (type I) in the liver. Endocrinology 1989;124:167-174.
53. Peterson ME, Ferguson DC, Kintzer PP, et al. Effects of spontaneous hyperadrenocorticism on serum thyroid hormone concentrations in the dog. Am J Vet Res 1984;45:2034-2038.
54. Lothrop CD, Nolan HL. Pituitary-thyroid function in canine Cushing's syndrome, in Proceedings. 3rd Annu ACVIM Forum, 1985;147.
55. Kemppainen RJ, Sartin JL. Differential regulation of peptide release by the canine pars distalis and pars intermedia. Front Horm Res 1987;17:18-27.